Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02386176 · ClinicalTrials.gov registry record
Assessment of Automated Breast Ultrasound
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 598
- Enrollment target
NCT02386176: Completed study, sponsored by University of Pittsburgh.
NCT02386176 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 598 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02386176 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 598 participants
- Enrollment target
Study Summary
The investigators are interested in assessing the value of and comparing the use of automated breast ultrasound (ABUS) (either as a primary screening approach or as a supplementary procedure) with digital breast tomosynthesis (DBT). The purpose of this project is to perform a preliminary prospective study on women who are most likely to benefit from the use of ABUS and/or DBT (or a combination of both) in the screening environment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 598 participants |
| Start Date | 2015-08 |
| Est. Completion | 2020-03 |
What the finished NCT02386176 record still lists
NCT02386176 is an observational study that tracks outcomes without assigning an intervention. The registered 598 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02386176 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02386176 about?
NCT02386176 is a clinical study titled "Assessment of Automated Breast Ultrasound". The investigators are interested in assessing the value of and comparing the use of automated breast ultrasound (ABUS) (either as a primary screening approach or as a supplementary procedure) with digital breast tomosynthesis (DBT). The purpose of this project is to perform a preliminary prospective...
What is the current status of trial NCT02386176?
This trial is currently completed. The enrollment target is 598 participants. The study started on 2015-08. Estimated completion is 2020-03.
Who is sponsoring clinical trial NCT02386176?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06875973 · 599 participants · Phase 3
Pelacarsen Roll-over Extension Program
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia